News
TUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics…
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
- Published on:
TUSTIN, Calif.and LONDONand BOSTON,Nov. 06, 2024(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development…
TUSTIN, Calif.,Sept. 12, 2024(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to…
TUSTIN, Calif.,May 23, 2024(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to…
TUSTIN, Calif.,Sept. 26, 2023(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…
TUSTIN, Calif.,May 10, 2023(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…
Company to Host Open House to Celebrate Official Launch of Newest CGMP Mammalian Cell Manufacturing Suites within Myford Facility First…
Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference
- Published on:
TUSTIN, Calif.,Nov. 02, 2022(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…
TUSTIN, Calif.,Sept. 27, 2022(GLOBE NEWSWIRE) –Avid Bioservices, Inc.(NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve…